Interferon regulatory factor 3 upregulates the Treg recruitment factor CCL22 in response to double-stranded DNA in cancer cells

JG Kim, JV Peña, HP McQueen, L Kong, D Michael… - bioRxiv, 2022 - biorxiv.org
Cancer immunotherapy holds great promise for the treatment of solid tumors, but its
effectiveness is hindered by the recruitment of regulatory T cells (Tregs), which inhibit anti …

Downstream STING pathways IRF3 and NF-κB differentially regulate CCL22 in response to cytosolic dsDNA

J Kim, JV Pena, HP McQueen, L Kong, D Michael… - Cancer Gene …, 2024 - nature.com
Double-stranded DNA (dsDNA) in the cytoplasm of eukaryotic cells is abnormal and typically
indicates the presence of pathogens or mislocalized self-DNA. Multiple sensors detect …

Context-dependent triggering of STING-interferon signaling by CD11b agonists supports anti-tumor immunity in mouse models and human cancer patients

X Liu, GD Hogg, C Zuo, JM Baer, VE Lander, L Kang… - bioRxiv, 2022 - biorxiv.org
Chronic activation of inflammatory pathways and suppressed interferon signaling are
hallmarks of myeloid cells in immunosuppressive tumors that drive poor responsiveness to …

Abstract A012: STING agonists drive intrinsic type I interferon responses in monocytes for optimal anti-tumor immunity

T Yu, M Girard, TH Watts - Cancer Immunology Research, 2023 - AACR
The cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway is
triggered by the sensing of cytosolic DNA, triggering the production of type I interferon (IFN-I) …

[HTML][HTML] T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer

H Ni, H Zhang, L Li, H Huang, H Guo… - … for Immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background Stimulator of interferon genes (STING) is an innate immune sensor of
cytoplasmic double-stranded DNA originating from microorganisms and host cells. The …

Immunotherapy with STING and TLR9 agonists promotes synergistic therapeutic efficacy with suppressed cancer-associated fibroblasts in colon carcinoma

S Hajiabadi, S Alidadi, Z Montakhab Farahi… - Frontiers in …, 2023 - frontiersin.org
The innate immune sensing of nucleic acids using effective immunoadjuvants is critical for
increasing protective immune responses against cancer. Stimulators of interferon genes …

[HTML][HTML] CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of TH1 and TH9 cells

I Benoit-Lizon, E Jacquin, TR Vargas… - … for immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background While stimulator of interferon genes (STING) activation in innate immune cells
of the tumor microenvironment can result in CD8 T cell-dependent antitumor immunity …

Innate immune signaling and regulation in cancer immunotherapy

L Corrales, V Matson, B Flood, S Spranger… - Cell research, 2017 - nature.com
A pre-existing T cell-inflamed tumor microenvironment has prognostic utility and also can be
predictive for response to contemporary cancer immunotherapies. The generation of a …

TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity

T Tani, H Mathsyaraja, M Campisi, ZH Li, K Haratani… - Cancer Discovery, 2024 - AACR
A substantial fraction of cancers evade immune detection by silencing Stimulator of
Interferon Genes (STING)-Interferon (IFN) signaling. Therapeutic reactivation of this program …

STING signaling remodels the tumor microenvironment by antagonizing myeloid-derived suppressor cell expansion

C Zhang, S Ye, J Ni, T Cai, Y Liu, D Huang… - Cell Death & …, 2019 - nature.com
Stimulator of interferon genes (STING), a major adaptor protein in antiviral innate immune
signaling, is considered as one of the most important regulators of antiviral and antitumor …